The Cardioband system provides a transcatheter approach for direct mitral valve annuloplasty to treat functional mitral regurgitation, with promising initial feasibility and safety.
Hypothesis-generating for transcatheter annuloplasty in functional MR; randomized trials needed before clinical adoption.
Direct mitral valve annuloplasty is a transcatheter mitral valve repair approach that mimics the conventional surgical approach to treat functional mitral regurgitation. The Cardioband system (Valtech Cardio, Inc., Or-Yehuda, Israel) is delivered by a trans-septal approach and the implant is performed on the atrial side of the mitral annulus, under live echo and fluoroscopic guidance using multiple anchor elements. The Cardioband system obtained CE mark approval in October 2015, and initial clinical experiences are promising with regard to feasibility, safety and efficacy.
No takes yet. Share an insight, caveat, or question.
Taramasso et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: